A child with a family history of convulsions following a diphtheria, tetanus and pertussis vaccinationĭiphtheria: The vaccine gives 87–98% protection from diphtheria and the disease is less severe in the 2–13% who have been immunised but who are not fully protected. A child with a family history of Sudden Unexplained Death of an lnfant (SUDI). A child with a history of convulsions, with or without fever, within three days of a previous pertussis vaccination. A child with a history of a hypotonic, hyporesponsive episode (HHE) within 48 hours of a previous pertussis vaccination. Infanrix hexa 6 series#
The potential risk of apnoea and the need for respiratory monitoring for 48-72 hours should be considered when administering the primary immunisation series to very premature infants (born ≤ 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity However, a lower immune response may be observed and the level of clinical protection remains unknown. The benefit of vaccination is high in this group of infants, and vaccination should not be withheld or delayed. In the case of a child with a clinically unstable evolving neurological disorder, withholding vaccination until the clinical situation has stabilised should be considered on an individual basis after careful consideration of the risks and benefits. It may, in this situation only, be given subcutaneously
Those with bleeding disorders, such as haemophilia The vaccine should be administered in accordance with the haematologist’s instructions. Specialist advice should be sought for the following groups: The presence of a minor infection is not a reason to delay immunisation 
Administration of Infanrix-hexa should be postponed in individuals suffering from a fever over 38☌. Anyone with severe allergy (anaphylaxis) to a previous dose of this vaccine or other diphtheria, tetanus, pertussis, polio, hepatitis B or Hib containing vaccine, or a component of the vaccine. Vaccine safety Infanrix-hexa should not be given to: Refer to Appendix 2 in the current Immunisation Handbook for further details on catch-up schedules and doses. Infanrix-hexa is funded for use in catch-up schedules in infants and children up to 10 th birthday. Infanrix-hexa should not be administered to children after their 10 th birthday, or to adults. Three doses are required for an infant or child to be fully immunised. The vaccine is administered intramuscularly, into the vastus lateralis. Separate syringes and different injection sites should be used. Infanrix-hexa can be administered concurrently with other vaccines, including all the National Immunisation Schedule vaccines. 
After reconstitution, the vaccine should be injected promptly.
The vaccine MUST be reconstituted by adding the entire contents of the supplied syringe to the vial containing the Hib pellet. Store as per cold chain between 2☌ to 8☌. Infanrix-hexa is funded for use in catch-up schedules for children up to their 10th birthday.
Infanrix-hexa is not funded for special groups. Infanrix ®-hexa is funded as part of the primary immunisation series from 6 weeks of age and is adminstered at 6 weeks, 3 and 5 months. Vaccine type: Combination subunit protein and inactivated virus vaccines Vaccine schedule and administration
0 kommentar(er)
